Coegin Pharma AB (NGM:COEGIN)
Sweden flag Sweden · Delayed Price · Currency is SEK
4.100
-0.070 (-1.68%)
At close: Apr 28, 2026

Coegin Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Market Capitalization
102110785197228
Upgrade
Market Cap Growth
-2.38%40.73%55.23%-47.61%-57.65%-
Upgrade
Enterprise Value
94103654492197
Upgrade
Last Close Price
4.104.443.855.3813.4636.01
Upgrade
PS Ratio
1291.111398.18----
Upgrade
PB Ratio
21.5023.293.117.494.5911.35
Upgrade
P/TBV Ratio
65.2270.624.09-10.4611.35
Upgrade
EV/Sales Ratio
-1304.89----
Upgrade
Net Debt / Equity Ratio
-1.67-1.67-0.78-0.82-0.18-1.28
Upgrade
Net Debt / EBITDA Ratio
0.460.460.970.220.120.94
Upgrade
Asset Turnover
0.000.00----
Upgrade
Quick Ratio
0.990.9911.700.710.842.95
Upgrade
Current Ratio
1.161.1611.710.720.852.96
Upgrade
Return on Equity (ROE)
-136.64%-136.64%-148.58%-201.53%-171.54%-147.59%
Upgrade
Return on Assets (ROA)
-63.31%-63.31%-68.67%-77.82%-72.78%-68.67%
Upgrade
Return on Capital Employed (ROCE)
-431.20%-431.20%-92.40%-412.00%-165.10%-135.40%
Upgrade
Earnings Yield
-20.10%-18.56%-30.30%-55.34%-36.52%-11.91%
Upgrade
Buyback Yield / Dilution
-31.30%-31.30%-105.53%-34.42%-15.36%-354.98%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.